185 related articles for article (PubMed ID: 35895046)
1. Association Between Early Left Ventricular Ejection Fraction Improvement After Transcatheter Aortic Valve Replacement and 5-Year Clinical Outcomes.
Kolte D; Bhardwaj B; Lu M; Alu MC; Passeri JJ; Inglessis I; Vlahakes GJ; Garcia S; Cohen DJ; Lindman BR; Kodali S; Thourani VH; Daubert MA; Douglas PS; Jaber W; Pibarot P; Clavel MA; Palacios IF; Leon MB; Smith CR; Mack MJ; Elmariah S
JAMA Cardiol; 2022 Sep; 7(9):934-944. PubMed ID: 35895046
[TBL] [Abstract][Full Text] [Related]
2. Transapical Transcatheter Aortic Valve Replacement Is Associated With Increased Cardiac Mortality in Patients With Left Ventricular Dysfunction: Insights From the PARTNER I Trial.
Elmariah S; Fearon WF; Inglessis I; Vlahakes GJ; Lindman BR; Alu MC; Crowley A; Kodali S; Leon MB; Svensson L; Pibarot P; Hahn RT; Thourani VH; Palacios IF; Miller DC; Douglas PS; Passeri JJ;
JACC Cardiovasc Interv; 2017 Dec; 10(23):2414-2422. PubMed ID: 29217004
[TBL] [Abstract][Full Text] [Related]
3. Effect of Baseline Left Ventricular Ejection Fraction on 2-Year Outcomes After Transcatheter Aortic Valve Replacement: Analysis of the PARTNER 2 Trials.
Furer A; Chen S; Redfors B; Elmariah S; Pibarot P; Herrmann HC; Hahn RT; Kodali S; Thourani VH; Douglas PS; Alu MC; Fearon WF; Passeri J; Malaisrie SC; Crowley A; McAndrew T; Genereux P; Ben-Yehuda O; Leon MB; Burkhoff D
Circ Heart Fail; 2019 Aug; 12(8):e005809. PubMed ID: 31525069
[TBL] [Abstract][Full Text] [Related]
4. Outcomes From Transcatheter Aortic Valve Replacement in Patients With Low-Flow, Low-Gradient Aortic Stenosis and Left Ventricular Ejection Fraction Less Than 30%: A Substudy From the TOPAS-TAVI Registry.
Maes F; Lerakis S; Barbosa Ribeiro H; Gilard M; Cavalcante JL; Makkar R; Herrmann HC; Windecker S; Enriquez-Sarano M; Cheema AN; Nombela-Franco L; Amat-Santos I; Muñoz-García AJ; Garcia Del Blanco B; Zajarias A; Lisko JC; Hayek S; Babaliaros V; Le Ven F; Gleason TG; Chakravarty T; Szeto W; Clavel MA; de Agustin A; Serra V; Schindler JT; Dahou A; Salah-Annabi M; Pelletier-Beaumont E; Côté M; Puri R; Pibarot P; Rodés-Cabau J
JAMA Cardiol; 2019 Jan; 4(1):64-70. PubMed ID: 30566185
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A).
Elmariah S; Palacios IF; McAndrew T; Hueter I; Inglessis I; Baker JN; Kodali S; Leon MB; Svensson L; Pibarot P; Douglas PS; Fearon WF; Kirtane AJ; Maniar HS; Passeri JJ;
Circ Cardiovasc Interv; 2013 Dec; 6(6):604-14. PubMed ID: 24221391
[TBL] [Abstract][Full Text] [Related]
6. Preprocedural valvuloarterial impedance as a predictor of left ventricular ejection fraction improvement after transcatheter aortic valve replacement in patients with reduced left ventricular ejection fraction.
Komatsu I; Hart C; Lau J; Spies C
Heart Vessels; 2020 Sep; 35(9):1209-1217. PubMed ID: 32253530
[TBL] [Abstract][Full Text] [Related]
7. Association of Renin-Angiotensin Inhibitor Treatment With Mortality and Heart Failure Readmission in Patients With Transcatheter Aortic Valve Replacement.
Inohara T; Manandhar P; Kosinski AS; Matsouaka RA; Kohsaka S; Mentz RJ; Thourani VH; Carroll JD; Kirtane AJ; Bavaria JE; Cohen DJ; Kiefer TL; Gaca JG; Kapadia SR; Peterson ED; Vemulapalli S
JAMA; 2018 Dec; 320(21):2231-2241. PubMed ID: 30512100
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Outcomes in Patients With New Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement.
Chamandi C; Barbanti M; Munoz-Garcia A; Latib A; Nombela-Franco L; Gutiérrez-Ibanez E; Veiga-Fernandez G; Cheema AN; Cruz-Gonzalez I; Serra V; Tamburino C; Mangieri A; Colombo A; Jiménez-Quevedo P; Elizaga J; Laughlin G; Lee DH; Garcia Del Blanco B; Rodriguez-Gabella T; Marsal JR; Côté M; Philippon F; Rodés-Cabau J
JACC Cardiovasc Interv; 2018 Feb; 11(3):301-310. PubMed ID: 29413244
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter Aortic Valve Replacement in Patients With Low-Flow, Low-Gradient Aortic Stenosis: The TOPAS-TAVI Registry.
Ribeiro HB; Lerakis S; Gilard M; Cavalcante JL; Makkar R; Herrmann HC; Windecker S; Enriquez-Sarano M; Cheema AN; Nombela-Franco L; Amat-Santos I; Muñoz-García AJ; Garcia Del Blanco B; Zajarias A; Lisko JC; Hayek S; Babaliaros V; Le Ven F; Gleason TG; Chakravarty T; Szeto WY; Clavel MA; de Agustin A; Serra V; Schindler JT; Dahou A; Puri R; Pelletier-Beaumont E; Côté M; Pibarot P; Rodés-Cabau J
J Am Coll Cardiol; 2018 Mar; 71(12):1297-1308. PubMed ID: 29566812
[TBL] [Abstract][Full Text] [Related]
10. Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER 2 Randomized Clinical Trial.
Baron SJ; Arnold SV; Wang K; Magnuson EA; Chinnakondepali K; Makkar R; Herrmann HC; Kodali S; Thourani VH; Kapadia S; Svensson L; Brown DL; Mack MJ; Smith CR; Leon MB; Cohen DJ;
JAMA Cardiol; 2017 Aug; 2(8):837-845. PubMed ID: 28658491
[TBL] [Abstract][Full Text] [Related]
11. Association of Transcatheter Aortic Valve Replacement With 30-Day Renal Function and 1-Year Outcomes Among Patients Presenting With Compromised Baseline Renal Function: Experience From the PARTNER 1 Trial and Registry.
Beohar N; Doshi D; Thourani V; Jensen H; Kodali S; Zhang F; Zhang Y; Davidson C; McCarthy P; Mack M; Kapadia S; Leon M; Kirtane A
JAMA Cardiol; 2017 Jul; 2(7):742-749. PubMed ID: 28467527
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Outcomes After Transcatheter vs Surgical Aortic Valve Replacement Among Patients at Intermediate Operative Risk With a History of Coronary Artery Bypass Graft Surgery: A Post Hoc Analysis of the SURTAVI Randomized Clinical Trial.
Reardon MJ; Heijmen RH; Van Mieghem NM; Williams MR; Yakubov SJ; Watson D; Kleiman NS; Conte J; Chawla A; Hockmuth D; Petrossian G; Robinson N; Kappetein AP; Li S; Popma JJ
JAMA Cardiol; 2019 Aug; 4(8):810-814. PubMed ID: 31215985
[TBL] [Abstract][Full Text] [Related]
13. Association of Structural and Functional Cardiac Changes With Transcatheter Aortic Valve Replacement Outcomes in Patients With Aortic Stenosis.
Fukui M; Gupta A; Abdelkarim I; Sharbaugh MS; Althouse AD; Elzomor H; Mulukutla S; Lee JS; Schindler JT; Gleason TG; Cavalcante JL
JAMA Cardiol; 2019 Mar; 4(3):215-222. PubMed ID: 30725109
[TBL] [Abstract][Full Text] [Related]
14. Impact of Ejection Fraction and Aortic Valve Gradient on Outcomes of Transcatheter Aortic Valve Replacement.
Baron SJ; Arnold SV; Herrmann HC; Holmes DR; Szeto WY; Allen KB; Chhatriwalla AK; Vemulapali S; O'Brien S; Dai D; Cohen DJ
J Am Coll Cardiol; 2016 May; 67(20):2349-2358. PubMed ID: 27199058
[TBL] [Abstract][Full Text] [Related]
15. Baseline global longitudinal strain by computed tomography is associated with post transcatheter aortic valve replacement outcomes.
Fukui M; Xu J; Thoma F; Sultan I; Mulukutla S; Elzomor H; Lee JS; Gleason TG; Cavalcante JL
J Cardiovasc Comput Tomogr; 2020; 14(3):233-239. PubMed ID: 31836414
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Implications of Change in Left Ventricular Ejection Fraction After Transcatheter Aortic Valve Implantation.
Kuneman JH; Butcher SC; Singh GK; Wang X; Hirasawa K; van der Kley F; Leon MB; Knuuti J; Pibarot P; Ajmone Marsan N; Delgado V; Bax JJ
Am J Cardiol; 2022 Aug; 177():90-99. PubMed ID: 35691708
[TBL] [Abstract][Full Text] [Related]
17. Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR: An Analysis of the PARTNER Trials and Registries.
Gonzales H; Douglas PS; Pibarot P; Hahn RT; Khalique OK; Jaber WA; Cremer P; Weissman NJ; Asch FM; Zhang Y; Gertz ZM; Elmariah S; Clavel MA; Thourani VH; Daubert M; Alu MC; Leon MB; Lindman BR
JACC Cardiovasc Interv; 2020 Jun; 13(11):1329-1339. PubMed ID: 32499024
[TBL] [Abstract][Full Text] [Related]
18. Quality-of-Life Outcomes After Transcatheter Aortic Valve Replacement in an Unselected Population: A Report From the STS/ACC Transcatheter Valve Therapy Registry.
Arnold SV; Spertus JA; Vemulapalli S; Li Z; Matsouaka RA; Baron SJ; Vora AN; Mack MJ; Reynolds MR; Rumsfeld JS; Cohen DJ
JAMA Cardiol; 2017 Apr; 2(4):409-416. PubMed ID: 28146260
[TBL] [Abstract][Full Text] [Related]
19. Regression of Left Ventricular Mass After Transcatheter Aortic Valve Replacement: The PARTNER Trials and Registries.
Chau KH; Douglas PS; Pibarot P; Hahn RT; Khalique OK; Jaber WA; Cremer P; Weissman NJ; Asch FM; Zhang Y; Gertz ZM; Elmariah S; Clavel MA; Thourani VH; Daubert M; Alu MC; Leon MB; Lindman BR
J Am Coll Cardiol; 2020 May; 75(19):2446-2458. PubMed ID: 32408979
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and safety of transcatheter aortic valve replacement in elderly people with severe aortic stenosis with different types of heart failure.
Dong M; Wang L; Tse G; Dai T; Wang L; Xiao Z; Liu T; Ren F
BMC Cardiovasc Disord; 2023 Jan; 23(1):34. PubMed ID: 36653770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]